Skip to content
Companies

PanTher Therapeutics

Absorbable film that delivers chemo directly to tumors

Raised to date

$3M

of $5M offered across 1 Form D filing

Still open
$2M
Investors
26
Last filed
Apr 3, 2025

About

PanTher Therapeutics, Inc. is a clinical-stage oncology company that focuses on revolutionizing cancer treatment through localized therapy. By addressing the inefficiencies of systemic drug delivery, PanTher aims to enhance cancer therapies and minimize side effects for patients.

PanTher stands out by delivering high-dose therapeutic agents directly to tumor sites, significantly minimizing systemic toxicity while maximizing drug effectiveness.

Funding

  • EquityFiled Apr 3, 2025Form D
    $3M/ $5M

Product

PTM-101

Oncology therapy

PTM-101 is an innovative, absorbable polymer film designed to deliver paclitaxel, a potent chemotherapy agent, directly to the peritumoral region. This targeted delivery method allows for sustained, high-dose administration while avoiding the systemic side effects typically associated with chemotherapy.

  • Flexible polymer film design
  • Continuous high-dose delivery directly to tissues
  • Reduces systemic side effects of traditional chemotherapy

Built for

Oncologists, interventional radiologists, and surgeons

People on file